RECRUITING

Use of Bone Marrow Concentrate for Treatment of Alar, Accessory, and Transverse Ligament Injuries

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to evaluate the effectiveness of using anterior approach through the posterior oropharynx for treating alar and transverse ligament injuries with bone marrow concentrate for patients with craniocervical junction (CCJ) instability.

Official Title

A Single-Blinded, Randomized Controlled Trial Evaluating the Use of Bone Marrow Concentrate for the Treatment of Alar, Accessory, and Transverse Ligament Injuries

Quick Facts

Study Start:2018-03-23
Study Completion:2025-06
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03517761

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 65 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Ehren R Dodson, PhD
CONTACT
720-287-7199
edodson@regenexx.com
Neven Steinmetz, PhD
CONTACT
nsteinmetz@regenexx.com

Principal Investigator

Christopher Centeno, MD
PRINCIPAL_INVESTIGATOR
Regenexx, LLC

Study Locations (Sites)

Ehren Dodson
Broomfield, Colorado, 80021
United States

Collaborators and Investigators

Sponsor: Regenexx, LLC

  • Christopher Centeno, MD, PRINCIPAL_INVESTIGATOR, Regenexx, LLC

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2018-03-23
Study Completion Date2025-06

Study Record Updates

Study Start Date2018-03-23
Study Completion Date2025-06

Terms related to this study

Keywords Provided by Researchers

  • CCJ
  • Bone Marrow Concentrate
  • Stem Cell Therapy
  • Alar Ligament
  • Transverse Ligament

Additional Relevant MeSH Terms

  • Craniocervical Injuries